Access cutting-edge glioblastoma treatment through this clinical trial at a research site in Houston. Study-provided care at no cost to qualified participants.
Access glioblastoma specialists in Houston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related glioblastoma treatment provided free
The goal of Phase 1 of this clinical research study is to find the highest tolerable dose and the recommended Phase 2 dose of ivonescimab that can be given to patients who have recurrent glioblastoma. The goal of Phase 2 of this clinical research study is to learn if the recommended Phase 2 dose of ivonescimab found in Phase 1 can help to control the disease.
Sponsor: M.D. Anderson Cancer Center
Check if you qualify for this glioblastoma clinical trial in Houston, TX
If you're searching for glioblastoma treatment options in Houston, TX, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Houston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced glioblastoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.